Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and III von Chatterjee, Sagnik, Mukherjee, Sambuddho, Sankara Sivaprasad, L.V.J., Naik, Tanvi, Gautam, Shashyendra Singh, Murali, Bokka Venkata, Hadambar, Avinash Annasao, Gunti, Gowtham Raj, Kuchibhotla, Vijaykumar, Deyati, Avisek, Basavanthappa, Sushma, Ramarao, Manjunath, Mariappan, T. Thanga, Zinker, Bradley A., Zhang, Yueping, Sinz, Michael, Shen, Hong

Volltext

Prodrug Strategy to Address Impaired Oral Absorption of a Weakly Basic TYK2 Inhibitor Caused by a Gastric Acid-Reducing Agent von A M Subbaiah, Murugaiah, Ramar, Thangeswaran, Reddy, Maheswara, Sivaprasad LVJ, Sankara, Yeshwante, Shekhar, Sridhar, Srikanth, Desai, Salil, Chiney, Manoj, Dierks, Elizabeth A., Mathur, Arvind, Moslin, Ryan, Weinstein, David S.

Volltext

Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic Steatohepatitis von Nara, Susheel J., Jogi, Srinivas, Cheruku, Srinivas, Kandhasamy, Sarkunam, Jaipuri, Firoz, Kathi, Pavan Kalyan, Reddy, Subba, Sarodaya, Sanket, Cook, Erica M., Wang, Tao, Sitkoff, Doree, Rossi, Karen A., Ruzanov, Max, Kiefer, Susan E., Khan, Javed A., Gao, Mian, Reddy, Satyanarayana, Sivaprasad LVJ, Sankara, Sane, Ramola, Mosure, Kathy, Zhuo, Xiaoliang, Cao, Gary G., Ziegler, Milinda, Azzara, Anthony, Krupinski, John, Soars, Matthew G., Ellsworth, Bruce A., Wacker, Dean A.

Volltext